£57.82Tax included
In stock
Orders placed before 3.30 pm are shipped on the same day
Decabolin is a prohormone supplement from Hi-Tech Pharmaceuticals, supplied in a bottle of 60 capsules and built around a precursor to Nandrolone.
The active compound is 19-NorAndrost-4-ene-3b-ol, 17th Decanoate, which the product information describes as converting effectively into Nandrolone.
According to the product information, 19-NorAndrost-4-ene-3b-ol is around three times more anabolic than pure testosterone, giving an androgenic ratio of 3:1.
The product information states that Decabolin does not increase estrogen levels and does not show strong aromatization, so gynecomastia is not a concern with it.
No. According to the product information it is not converted into DHT, so hair loss is not associated with its use.
Nandrolone is popular among bodybuilders who experience joint pain because it is described as helping to lubricate the joints.
Cyclosome is the delivery technology used by Hi-Tech Pharmaceuticals in Decabolin to improve how the active compound is absorbed.
The stated dosage is one tablet in the morning and one in the evening, without exceeding two tablets a day.
Each bottle of Hi-Tech Pharmaceuticals Decabolin contains 60 capsules.
It is aimed at serious athletes looking for a prohormone that supports muscle growth and strength alongside joint support.
CrossTheLimits is proud to announce that it has become an official distributor of Hi-Tech Pharmaceuticals products in the United Kingdom! This partnership with Hi-Tech Pharmaceuticals allows CrossTheLimits to offer cutting-edge supplements and nutritional products directly to fitness enthusiasts and dedicated athletes across the UK.
Hi-Tech Pharmaceuticals is renowned for its commitment to innovative formulations that deliver tangible results. As industry leaders, they have consistently set the standard for high-quality supplements that support a range of fitness goals, from muscle building and weight management to enhanced endurance and recovery.
No product reviews yet — add the first one!